Viewing Study NCT00089193


Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-02-26 @ 2:18 AM
Study NCT ID: NCT00089193
Status: COMPLETED
Last Update Posted: 2014-12-23
First Post: 2004-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
Sponsor: Craig L Slingluff, Jr
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II melanoma View
None stage III melanoma View
None stage IV melanoma View
None recurrent melanoma View